APA (7th ed.) Citation

I, Z., N, L., P, G., TL, R., S, J., O, M., . . . F, L. (2023). Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. Cancer gene therapy, 30(6), 926. https://doi.org/10.1038/s41417-023-00594-2

Chicago Style (17th ed.) Citation

I, Zaffran, Landolina N, Gaur P, Rovis TL, Jonjic S, Mandelboim O, Singer BB, and Levi-Schaffer F. "Correction to: Activation of CEACAM1 with an Agonistic Monoclonal Antibody Results in Inhibition of Melanoma Cells." Cancer Gene Therapy 30, no. 6 (2023): 926. https://doi.org/10.1038/s41417-023-00594-2.

MLA (9th ed.) Citation

I, Zaffran, et al. "Correction to: Activation of CEACAM1 with an Agonistic Monoclonal Antibody Results in Inhibition of Melanoma Cells." Cancer Gene Therapy, vol. 30, no. 6, 2023, p. 926, https://doi.org/10.1038/s41417-023-00594-2.